The Discounted Cash Flow (DCF) valuation of Cytosorbents Corp (CTSO) is (6.31) USD. With the latest stock price at 0.66 USD, the upside of Cytosorbents Corp based on DCF is -1062.5%.
Based on the latest price of 0.66 USD and our DCF valuation, Cytosorbents Corp (CTSO) is a sell. selling CTSO stocks now will result in a potential gain of 1062.5%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.8% - 9.8% | 7.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (29.56) - (3.69) | (6.31) |
| Upside | -4607.6% - -662.3% | -1062.5% |